{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:50:45Z","timestamp":1791561045268,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"32","license":[{"start":{"date-parts":[[2010,5,31]],"date-time":"2010-05-31T00:00:00Z","timestamp":1275264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,5,31]],"date-time":"2010-05-31T00:00:00Z","timestamp":1275264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2010,8,12]]},"DOI":"10.1038\/onc.2010.203","type":"journal-article","created":{"date-parts":[[2010,5,31]],"date-time":"2010-05-31T15:43:55Z","timestamp":1275320635000},"page":"4588-4598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["TLR9 triggering in Burkitt's lymphoma cell lines suppresses the EBV BZLF1 transcription via histone modification"],"prefix":"10.1038","volume":"29","author":[{"given":"L","family":"Zauner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G T","family":"Melroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Sigrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M P","family":"Rechsteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Dorner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B W","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R F","family":"Speck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,31]]},"reference":[{"key":"BFonc2010203_CR1","doi-asserted-by":"publisher","first-page":"8166","DOI":"10.1128\/JVI.77.14.8166-8172.2003","volume":"77","author":"N Alazard","year":"2003","unstructured":"Alazard N, Gruffat H, Hiriart E, Sergeant A, Manet E . (2003). Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin. J Virol 77: 8166\u20138172.","journal-title":"J Virol"},{"key":"BFonc2010203_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/intimm\/dxh222","volume":"17","author":"RF Ashman","year":"2005","unstructured":"Ashman RF, Goeken JA, Drahos J, Lenert P . (2005). Sequence requirements for oligodeoxyribonucleotide inhibitory activity. Int Immunol 17: 411\u2013420.","journal-title":"Int Immunol"},{"key":"BFonc2010203_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jmv.1078","volume":"64","author":"C Berger","year":"2001","unstructured":"Berger C, Day P, Meier G, Zingg W, Bossart W, Nadal D . (2001). Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol 64: 505\u2013512.","journal-title":"J Med Virol"},{"key":"BFonc2010203_CR4","doi-asserted-by":"publisher","first-page":"8532","DOI":"10.1128\/JVI.77.15.8532-8540.2003","volume":"77","author":"HJ Brown","year":"2003","unstructured":"Brown HJ, Song MJ, Deng H, Wu TT, Cheng G, Sun R . (2003). NF-kappaB inhibits gammaherpesvirus lytic replication. J Virol 77: 8532\u20138540.","journal-title":"J Virol"},{"key":"BFonc2010203_CR5","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1371\/journal.ppat.0030080","volume":"3","author":"A Chene","year":"2007","unstructured":"Chene A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, Falk KI et al. (2007). A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog 3: e80.","journal-title":"PLoS Pathog"},{"key":"BFonc2010203_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.chom.2009.12.003","volume":"7","author":"C Coban","year":"2009","unstructured":"Coban C, Igari Y, Yagi M, Reimer T, Koyama S, Aoshi T et al. (2009). Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9. Cell Host Microbe 7: 50\u201361.","journal-title":"Cell Host Microbe"},{"key":"BFonc2010203_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1084\/jem.20041836","volume":"201","author":"C Coban","year":"2005","unstructured":"Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, Uematsu S et al. (2005). Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med 201: 19\u201325.","journal-title":"J Exp Med"},{"key":"BFonc2010203_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI . (2000). Epstein-Barr virus infection. N Engl J Med 343: 481\u2013492.","journal-title":"N Engl J Med"},{"key":"BFonc2010203_CR9","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1128\/JVI.00116-08","volume":"82","author":"JK Countryman","year":"2008","unstructured":"Countryman JK, Gradoville L, Miller G . (2008). Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. J Virol 82: 4706\u20134719.","journal-title":"J Virol"},{"key":"BFonc2010203_CR10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"AJ de Ruijter","year":"2003","unstructured":"de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB . (2003). Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370: 737\u2013749.","journal-title":"Biochem J"},{"key":"BFonc2010203_CR11","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/ijc.2910570623","volume":"57","author":"L di Renzo","year":"1994","unstructured":"di Renzo L, Altiok A, Klein G, Klein E . (1994). Endogenous TGF-beta contributes to the induction of the EBV lytic cycle in two Burkitt lymphoma cell lines. Int J Cancer 57: 914\u2013919.","journal-title":"Int J Cancer"},{"key":"BFonc2010203_CR12","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.4049\/jimmunol.174.9.5193","volume":"174","author":"O Duramad","year":"2005","unstructured":"Duramad O, Fearon KL, Chang B, Chan JH, Gregorio J, Coffman RL et al. (2005). Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation. J Immunol 174: 5193\u20135200.","journal-title":"J Immunol"},{"key":"BFonc2010203_CR13","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.1128\/jvi.65.12.7073-7077.1991","volume":"65","author":"EK Flemington","year":"1991","unstructured":"Flemington EK, Goldfeld AE, Speck SH . (1991). Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis. J Virol 65: 7073\u20137077.","journal-title":"J Virol"},{"key":"BFonc2010203_CR14","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/nature05836","volume":"447","author":"SL Foster","year":"2007","unstructured":"Foster SL, Hargreaves DC, Medzhitov R . (2007). Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972\u2013978.","journal-title":"Nature"},{"key":"BFonc2010203_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijmm.2007.07.007","volume":"298","author":"K Heeg","year":"2008","unstructured":"Heeg K, Dalpke A, Peter M, Zimmermann S . (2008). Structural requirements for uptake and recognition of CpG oligonucleotides. Int J Med Microbiol 298: 33\u201338.","journal-title":"Int J Med Microbiol"},{"key":"BFonc2010203_CR16","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","volume":"168","author":"V Hornung","year":"2002","unstructured":"Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T et al. (2002). Quantitative expression of toll-like receptor 1\u201310 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168: 4531\u20134537.","journal-title":"J Immunol"},{"key":"BFonc2010203_CR17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.chom.2008.05.003","volume":"3","author":"KJ Ishii","year":"2008","unstructured":"Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S . (2008). Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3: 352\u2013363.","journal-title":"Cell Host Microbe"},{"key":"BFonc2010203_CR18","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.4049\/jimmunol.172.3.1561","volume":"172","author":"D Iwakiri","year":"2004","unstructured":"Iwakiri D, Takada K . (2004). Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation. J Immunol 172: 1561\u20131566.","journal-title":"J Immunol"},{"key":"BFonc2010203_CR19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/JVI.74.2.710-720.2000","volume":"74","author":"PJ Jenkins","year":"2000","unstructured":"Jenkins PJ, Binne UK, Farrell PJ . (2000). Histone acetylation and reactivation of Epstein-Barr virus from latency. J Virol 74: 710\u2013720.","journal-title":"J Virol"},{"key":"BFonc2010203_CR20","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/sj.onc.1210240","volume":"26","author":"E Klein","year":"2007","unstructured":"Klein E, Kis LL, Klein G . (2007). Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions. Oncogene 26: 1297\u20131305.","journal-title":"Oncogene"},{"key":"BFonc2010203_CR21","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1074\/jbc.M413541200","volume":"280","author":"G Krishnegowda","year":"2005","unstructured":"Krishnegowda G, Hajjar AM, Zhu J, Douglass EJ, Uematsu S, Akira S et al. (2005). Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem 280: 8606\u20138616.","journal-title":"J Biol Chem"},{"key":"BFonc2010203_CR22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.addr.2007.12.004","volume":"60","author":"Y Kumagai","year":"2008","unstructured":"Kumagai Y, Takeuchi O, Akira S . (2008). TLR9 as a key receptor for the recognition of DNA. Adv Drug Deliv Rev 60: 795\u2013804.","journal-title":"Adv Drug Deliv Rev"},{"key":"BFonc2010203_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1146\/annurev.immunol.17.1.555","volume":"17","author":"T Kurosaki","year":"1999","unstructured":"Kurosaki T . (1999). Genetic analysis of B cell antigen receptor signaling. Annu Rev Immunol 17: 555\u2013592.","journal-title":"Annu Rev Immunol"},{"key":"BFonc2010203_CR24","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1111\/j.1462-5822.2007.00937.x","volume":"9","author":"K Ladell","year":"2007","unstructured":"Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M et al. (2007). Immune activation suppresses initiation of lytic Epstein-Barr virus infection. Cell Microbiol 9: 2055\u20132069.","journal-title":"Cell Microbiol"},{"key":"BFonc2010203_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0042-6822(79)90455-0","volume":"94","author":"J Luka","year":"1979","unstructured":"Luka J, Kallin B, Klein G . (1979). Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94: 228\u2013231.","journal-title":"Virology"},{"key":"BFonc2010203_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cyto.990170205","volume":"17","author":"EJ Novak","year":"1994","unstructured":"Novak EJ, Rabinovitch PS . (1994). Improved sensitivity in flow cytometric intracellular ionized calcium measurement using fluo-3\/Fura Red fluorescence ratios. Cytometry 17: 135\u2013141.","journal-title":"Cytometry"},{"key":"BFonc2010203_CR27","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1073\/pnas.0608745104","volume":"104","author":"P Parroche","year":"2007","unstructured":"Parroche P, Lauw FN, Goutagny N, Latz E, Monks BG, Visintin A et al. (2007). From the cover: malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci USA 104: 1919\u20131924.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2010203_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.coi.2005.03.003","volume":"17","author":"SL Peng","year":"2005","unstructured":"Peng SL . (2005). Signaling in B cells via Toll-like receptors. Curr Opin Immunol 17: 230\u2013236.","journal-title":"Curr Opin Immunol"},{"key":"BFonc2010203_CR29","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1099\/vir.0.82790-0","volume":"88","author":"MP Rechsteiner","year":"2007","unstructured":"Rechsteiner MP, Berger C, Weber M, Sigrist JA, Nadal D, Bernasconi M . (2007). Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells. J Gen Virol 88: 1454\u20131459.","journal-title":"J Gen Virol"},{"key":"BFonc2010203_CR30","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1128\/JVI.01723-07","volume":"82","author":"MP Rechsteiner","year":"2008","unstructured":"Rechsteiner MP, Berger C, Zauner L, Sigrist JA, Weber M, Longnecker R et al. (2008). Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection. J Virol 82: 1739\u20131747.","journal-title":"J Virol"},{"key":"BFonc2010203_CR31","volume-title":"Fields Virology","author":"A Rickinson","year":"2007","unstructured":"Rickinson A, Kieff E . (2007). Epstein-Barr Virus. In: Knipe D, Howley P (eds). Fields Virology, Lippincott Williams & Wilkins: Philadelphia."},{"key":"BFonc2010203_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrmicro1089","volume":"3","author":"R Rochford","year":"2005","unstructured":"Rochford R, Cannon MJ, Moormann AM . (2005). Endemic Burkitt's lymphoma: a polymicrobial disease? Nat Rev Microbiol 3: 182\u2013187.","journal-title":"Nat Rev Microbiol"},{"key":"BFonc2010203_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/00019606-200406000-00001","volume":"13","author":"JL Ryan","year":"2004","unstructured":"Ryan JL, Fan H, Swinnen LJ, Schichman SA, Raab-Traub N, Covington M et al. (2004). Epstein-Barr virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies. Diagn Mol Pathol 13: 61\u201368.","journal-title":"Diagn Mol Pathol"},{"key":"BFonc2010203_CR34","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1083\/jcb.200508058","volume":"172","author":"MA Sanjuan","year":"2006","unstructured":"Sanjuan MA, Rao N, Lai KT, Gu Y, Sun S, Fuchs A et al. (2006). CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J Cell Biol 172: 1057\u20131068.","journal-title":"J Cell Biol"},{"key":"BFonc2010203_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ijc.2910330106","volume":"33","author":"K Takada","year":"1984","unstructured":"Takada K . (1984). Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 33: 27\u201332.","journal-title":"Int J Cancer"},{"key":"BFonc2010203_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.smim.2003.10.009","volume":"16","author":"F Takeshita","year":"2004","unstructured":"Takeshita F, Gursel I, Ishii KJ, Suzuki K, Gursel M, Klinman DM . (2004). Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. Semin Immunol 16: 17\u201322.","journal-title":"Semin Immunol"},{"key":"BFonc2010203_CR37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/276270a0","volume":"276","author":"MG Tovey","year":"1978","unstructured":"Tovey MG, Lenoir G, Begon-Lours J . (1978). Activation of latent Epstein-Barr virus by antibody to human IgM. Nature 276: 270\u2013272.","journal-title":"Nature"},{"key":"BFonc2010203_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/rmv.441","volume":"15","author":"T Tsurumi","year":"2005","unstructured":"Tsurumi T, Fujita M, Kudoh A . (2005). Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol 15: 3\u201315.","journal-title":"Rev Med Virol"},{"key":"BFonc2010203_CR39","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/intimm\/11.12.2015","volume":"11","author":"AK Yi","year":"1999","unstructured":"Yi AK, Peckham DW, Ashman RF, Krieg AM . (1999). CpG DNA rescues B cells from apoptosis by activating NFkappaB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway. Int Immunol 11: 2015\u20132024.","journal-title":"Int Immunol"},{"key":"BFonc2010203_CR40","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1128\/JVI.80.5.2548-2565.2006","volume":"80","author":"J Yuan","year":"2006","unstructured":"Yuan J, Cahir-McFarland E, Zhao B, Kieff E . (2006). Virus and cell RNAs expressed during Epstein-Barr virus replication. J Virol 80: 2548\u20132565.","journal-title":"J Virol"},{"key":"BFonc2010203_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/272373a0","volume":"272","author":"H zur Hausen","year":"1978","unstructured":"zur Hausen H, O'Neill FJ, Freese UK, Hecker E . (1978). Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 272: 373\u2013375.","journal-title":"Nature"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2010203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010203","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T17:30:44Z","timestamp":1647883844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2010203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,31]]},"references-count":41,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2010,8,12]]}},"alternative-id":["BFonc2010203"],"URL":"https:\/\/doi.org\/10.1038\/onc.2010.203","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,31]]},"assertion":[{"value":"6 January 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}